Cambiar Investors’s AstraZeneca AZN Stock Holding History

Cambiar Investors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15,000	Closed	-$986K	–	157
2016 Q3	$986K	Sell	15,000 -60,000	-80%	-$3.92M	0.01%	145
2016 Q2	$4.53M	Hold	75,000	–	–	0.06%	109
2016 Q1	$4.22M	Hold	75,000	–	–	0.06%	104
2015 Q4	$5.09M	Hold	75,000	–	–	0.07%	111
2015 Q3	$4.77M	Buy	75,000 +25,000	+50%	+$1.64M	0.07%	123
2015 Q2	$3.19M	Buy	+50,000	New	+$3.42M	0.04%	113

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Cambiar Investors's AZN Position: Q2 2026 in Review

Cambiar Investors reduced its AstraZeneca (AZN) stake by 2.8% in Q2 2026, selling an estimated $696K and leaving 129,899 shares worth $24.6M. The position accounts for 1.07% of the portfolio, ranked #43.

Cambiar Investors first reported a position in AZN in Q2 2015 and has held it in 11 quarters since. The position peaked at $233M in Q4 2015. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Cambiar Investors held 129,899 shares of AstraZeneca worth $24.6M as of Q2 2026.
Cambiar Investors sold 3,700 AstraZeneca shares in Q2 2026, an estimated $696K.
AstraZeneca made up 1.07% of Cambiar Investors's portfolio in Q2 2026, its #43 holding.
Cambiar Investors first reported a position in AstraZeneca in Q2 2015 and has held it in 11 quarters since.
Cambiar Investors's AstraZeneca position peaked at $233M in Q4 2015.
906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cambiar Investors's 13F filing for Q2 2026, filed 31 Jul 2026.